Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:15 AM
Ignite Modification Date:
2025-12-26 @ 12:45 AM
NCT ID:
NCT03020160
Group ID:
EG001
Title:
Emicizumab: Expansion Cohort
Description:
Participants received emicizumab subcutaneously (SC) at a loading dose of 3 mg/kg once every week for the first 4 weeks followed by a maintenance dose of 6 mg/kg emicizumab SC once every 4 weeks (Q4W) for at least 24 weeks. Upon implementation of protocol version 5 (20-Dec-2019), each participant was given the option to choose a preferred emicizumab dosing regimen among those permitted (i.e., emicizumab SC 1.5 mg/kg once every week \[QW\], 3 mg/kg once every 2 weeks \[Q2W\], or 6 mg/kg Q4W) and continue on that dosing regimen until discontinuation from the study.
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
8
Serious Number At Risk:
41
Other Number Affected:
37
Other Number At Risk:
41
Study:
NCT03020160
Results Section:
NCT03020160
Adverse Events Module:
NCT03020160